Starpharma Halts Trading Pending Strategic Transaction Update
Key points
- Starpharma Holdings requests trading halt on securities
- Halt requested pending announcement on strategic transaction
- Expected announcement before trading resumes on 20th October 2026
- Trading halt will remain until announcement or trading resumes
- No reason provided for not granting the halt
Full summary
Starpharma Holdings Limited (ASX: SPL) has requested a trading halt on its securities until an announcement is made regarding an update on a strategic transaction. The halt is expected to remain in effect until the earlier of the opening of trading on Tuesday, October 20, 2026, or when the announcement is released. The company does not foresee any reason why the halt should not be granted by the ASX.
Summary generated by a large language model. Please interpret with care.